Intrinsic Vascular Repair by Endothelial Progenitor Cells in Acute Coronary Syndromes: an Update Overview

[1]  R. Negro,et al.  Active Stromal Cell–Derived Factor 1α and Endothelial Progenitor Cells are Equally Increased by Alogliptin in Good and Poor Diabetes Control , 2017, Clinical medicine insights. Endocrinology and diabetes.

[2]  A. Sacchetti,et al.  Improving the characterization of endothelial progenitor cell subsets by an optimized FACS protocol , 2017, PloS one.

[3]  Jeffrey L. Anderson,et al.  Acute Myocardial Infarction. , 2017, The New England journal of medicine.

[4]  A. Avogaro,et al.  Levels of Circulating Progenitor Cells, Cardiovascular Outcomes and DeathNovelty and Significance , 2016 .

[5]  Ki-Sook Park,et al.  Substance P enhances EPC mobilization for accelerated wound healing , 2016, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[6]  A. D'Ascola,et al.  Endothelial Progenitor Cells for Diagnosis and Prognosis in Cardiovascular Disease , 2015, Stem cells international.

[7]  R. Rakhit,et al.  Acute coronary syndromes. , 2016, Clinical medicine.

[8]  J. Filep,et al.  C-reactive protein and inflammation: conformational changes affect function , 2015, Biological chemistry.

[9]  A. Oliveras,et al.  Endothelial Progenitor Cells Predict Cardiovascular Events after Atherothrombotic Stroke and Acute Myocardial Infarction. A PROCELL Substudy , 2015, PloS one.

[10]  Roland Zengerle,et al.  Technologies for Single-Cell Isolation , 2015, International journal of molecular sciences.

[11]  T. Jernberg,et al.  Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective. , 2015, European heart journal.

[12]  A. Oliveras,et al.  Mobilization of endothelial progenitor cells in acute cardiovascular events in the PROCELL study: time-course after acute myocardial infarction and stroke. , 2015, Journal of molecular and cellular cardiology.

[13]  Liang-Yu Lin,et al.  Effects of pitavastatin versus atorvastatin on the peripheral endothelial progenitor cells and vascular endothelial growth factor in high-risk patients: a pilot prospective, double-blind, randomized study , 2014, Cardiovascular Diabetology.

[14]  R. Fernandes,et al.  Reduced levels of circulating endothelial progenitor cells in acute myocardial infarction patients with diabetes or pre-diabetes: accompanying the glycemic continuum , 2014, Cardiovascular Diabetology.

[15]  P. Peplow.  Influence of growth factors and cytokines on angiogenic function of endothelial progenitor cells: a review of in vitro human studies , 2014, Growth factors.

[16]  Andrew Hopkinson,et al.  Concise Review: Evidence for CD34 as a Common Marker for Diverse Progenitors , 2014, Stem cells.

[17]  P. Boutouyrie,et al.  Forearm ischemia decreases endothelial colony-forming cell angiogenic potential. , 2014, Cytotherapy.

[18]  A. Ibrahim,et al.  Acute myocardial infarction. , 2014, Critical care clinics.

[19]  W. Holnthoner,et al.  Three specific antigens to isolate endothelial progenitor cells from human liposuction material. , 2013, Cytotherapy.

[20]  Shing‐Jong Lin,et al.  Clinical Application of Endothelial Progenitor Cell: Are We Ready? , 2013, Acta Cardiologica Sinica.

[21]  C. Specchia,et al.  Migratory activity of circulating progenitor cells and serum SDF-1α predict adverse events in patients with myocardial infarction. , 2013, Cardiovascular research.

[22]  Lei Lv,et al.  Potential mechanism for endothelial progenitor cell therapy in acute myocardial infarction: Activation of VEGF- PI3K/Akte-NOS pathway. , 2013, Annals of clinical and laboratory science.

[23]  A. M. Leone,et al.  Endothelial progenitor cells, microvascular obstruction, and left ventricular remodeling in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention. , 2013, The American journal of cardiology.

[24]  T. Crombleholme,et al.  The Role of Endothelial Progenitor Cells in Postnatal Vasculogenesis: Implications for Therapeutic Neovascularization and Wound Healing. , 2013, Advances in wound care.

[25]  M. Yoder.  Endothelial progenitor cell: a blood cell by many other names may serve similar functions , 2013, Journal of Molecular Medicine.

[26]  A. Mathur,et al.  The effects of age, disease state, and granulocyte colony-stimulating factor on progenitor cell count and function in patients undergoing cell therapy for cardiac disease. , 2013, Stem cells and development.

[27]  Manesh R. Patel,et al.  EPC mobilization after erythropoietin treatment in acute ST-elevation myocardial infarction: the REVEAL EPC substudy , 2012, Journal of Thrombosis and Thrombolysis.

[28]  Xin Yi,et al.  A novel and feasible way to cultivate and purify endothelial progenitor cells from bone marrow of children with congenital heart diseases , 2012 .

[29]  M. Yoder.  Human endothelial progenitor cells. , 2012, Cold Spring Harbor perspectives in medicine.

[30]  S. Dimmeler,et al.  Critical Reevaluation of Endothelial Progenitor Cell Phenotypes for Therapeutic and Diagnostic Use , 2012, Circulation research.

[31]  A. Griffioen,et al.  CD34 marks angiogenic tip cells in human vascular endothelial cell cultures , 2012, Angiogenesis.

[32]  V. Serebruany,et al.  Endothelial Progenitor Cells and Left Ventricle Function in Patients With Acute Myocardial Infarction: Potential Therapeutic Considertions , 2012, American journal of therapeutics.

[33]  Hong Wang,et al.  Endothelial progenitor cells in atherosclerosis. , 2012, Frontiers in bioscience.

[34]  Jin Gao,et al.  A novel and feasible way to cultivate and purify endothelial progenitor cells from bone marrow of children with congenital heart diseases. , 2012, Chinese medical journal.

[35]  G. Paxinos,et al.  Current therapy of non-ST-elevation acute coronary syndromes. , 2012, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

[36]  A. Griffioen,et al.  CD34 marks angiogenic tip cells in human vascular endothelial cell cultures , 2012, Angiogenesis.

[37]  B. Krock,et al.  Hypoxia-induced angiogenesis: good and evil. , 2011, Genes & cancer.

[38]  J. Marchal,et al.  Influence of preinfarction angina on the release kinetics of endothelial progenitor cells and cytokines during the week after infarction , 2011, European journal of clinical investigation.

[39]  A. M. Leone,et al.  Are endothelial progenitor cells mobilized by myocardial ischemia or myocardial necrosis? A cardiac magnetic resonance study. , 2011, Atherosclerosis.

[40]  P. Libby,et al.  Progress and challenges in translating the biology of atherosclerosis , 2011, Nature.

[41]  C. Stefanadis,et al.  The role of endothelial progenitor cells in vascular repair after arterial injury and atherosclerotic plaque development. , 2011, Cardiovascular therapeutics.

[42]  J. Lekakis,et al.  Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on Peripheral Circulation , 2011, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[43]  Mayank K. Mittal,et al.  Endothelial progenitor cells as factors in neovascularization and endothelial repair. , 2010, World journal of cardiology.

[44]  J. Y. Kim,et al.  Human Cord Blood-Derived Endothelial Progenitor Cells and Their Conditioned Media Exhibit Therapeutic Equivalence for Diabetic Wound Healing , 2010, Cell transplantation.

[45]  S. Fichtlscherer,et al.  Quantification of Circulating Endothelial Progenitor Cells Using the Modified ISHAGE Protocol , 2010, PloS one.

[46]  K. Pollok,et al.  Application of polychromatic flow cytometry to identify novel subsets of circulating cells with angiogenic potential , 2010, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[47]  De-cai Yu,et al.  Hypoxic and Highly Angiogenic Non-Tumor Tissues Surrounding Hepatocellular Carcinoma: The ‘Niche’ of Endothelial Progenitor Cells , 2010, International journal of molecular sciences.

[48]  U. Singh,et al.  Decreased number and impaired functionality of endothelial progenitor cells in subjects with metabolic syndrome: implications for increased cardiovascular risk. , 2010, Atherosclerosis.

[49]  K. Hirschi,et al.  Hemato-vascular origins of endothelial progenitor cells? , 2010, Microvascular research.

[50]  C. Seiler,et al.  The human coronary collateral circulation , 2010, European journal of clinical investigation.

[51]  T. Connolly,et al.  Biomarkers of vulnerable atheromatous plaques: translational medicine perspectives. , 2010, Advances in clinical chemistry.

[52]  P. Chowienczyk,et al.  Progenitors in motion: mechanisms of mobilization of endothelial progenitor cells. , 2009, British journal of clinical pharmacology.

[53]  Dingcheng Gao,et al.  The role of bone-marrow-derived cells in tumor growth, metastasis initiation and progression. , 2009, Trends in molecular medicine.

[54]  Hsiao-Ya Tsai,et al.  Matrix Metalloproteinase-9 Is Essential for Ischemia-Induced Neovascularization by Modulating Bone Marrow–Derived Endothelial Progenitor Cells , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[55]  G. Niccoli,et al.  Comparison of the effects of ramipril versus telmisartan on high-sensitivity C-reactive protein and endothelial progenitor cells after acute coronary syndrome. , 2009, The American journal of cardiology.

[56]  A. Sirker,et al.  Vascular progenitor cells and translational research: the role of endothelial and smooth muscle progenitor cells in endogenous arterial remodelling in the adult. , 2009, Clinical science.

[57]  C. DeSouza,et al.  Gender and Endothelial Progenitor Cell Number in Middle-Aged Adults. , 2008, Artery research.

[58]  T. Akasaka,et al.  Endothelial Progenitor Cells Dysfunction and Senescence: Contribution to Oxidative Stress , 2008, Current cardiology reviews.

[59]  J. Roh,et al.  Circulating Endothelial Progenitor Cells as a New Marker of Endothelial Dysfunction or Repair in Acute Stroke , 2008, Stroke.

[60]  A. Avogaro,et al.  Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau. , 2008, Atherosclerosis.

[61]  Xiaoping Liu,et al.  MAPK/ERK signalling mediates VEGF-induced bone marrow stem cell differentiation into endothelial cell , 2008, Journal of cellular and molecular medicine.

[62]  Sherrif F Ibrahim,et al.  Flow cytometry and cell sorting. , 2013, Advances in biochemical engineering/biotechnology.

[63]  G. Nickenig,et al.  Endothelial progenitor cells correlate with endothelial function in patients with coronary artery disease , 2007, Basic Research in Cardiology.

[64]  S. Rafii,et al.  The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. , 2007, Trends in immunology.

[65]  D. Scheinberg,et al.  Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. , 2007, Genes & development.

[66]  K. Mandal,et al.  Characterisation of progenitor cells in human atherosclerotic vessels. , 2007, Atherosclerosis.

[67]  A. Simon,et al.  Decreased number of circulating CD34+KDR+ cells in asymptomatic subjects with preclinical atherosclerosis. , 2007, Atherosclerosis.

[68]  J. Prchal,et al.  Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. , 2007, Blood.

[69]  G. Lip,et al.  Endothelial colony forming units: Are they a reliable marker of endothelial progenitor cell numbers? , 2007, Annals of medicine.

[70]  N. Chaturvedi,et al.  Reduced endothelial progenitor cells in European and South Asian men with atherosclerosis , 2007, European journal of clinical investigation.

[71]  W. Bloch,et al.  Endothelial progenitor cells: a new target for the prevention of cardiovascular diseases , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[72]  A. Avogaro,et al.  Peripheral Blood CD34+KDR+ Endothelial Progenitor Cells Are Determinants of Subclinical Atherosclerosis in a Middle-Aged General Population , 2006, Stroke.

[73]  O. Kollet,et al.  Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice. , 2006, Experimental hematology.

[74]  K. Okumura,et al.  The Impact of the Capability of Circulating Progenitor Cell to Differentiate on Myocardial Salvage in Patients With Primary Acute Myocardial Infarction , 2006, Circulation.

[75]  F. Magrini,et al.  Endothelial colony forming capacity is related to C-reactive protein levels in healthy subjects. , 2006, Current neurovascular research.

[76]  H. Reichenspurner,et al.  Vascular wall resident progenitor cells: a source for postnatal vasculogenesis , 2006, Development.

[77]  G. Nickenig,et al.  CD34−/CD133+/VEGFR-2+ Endothelial Progenitor Cell Subpopulation With Potent Vasoregenerative Capacities , 2006, Circulation research.

[78]  G. Nickenig,et al.  Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy? , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[79]  G. Nickenig,et al.  Circulating endothelial progenitor cells and cardiovascular outcomes. , 2005, The New England journal of medicine.

[80]  Z. Estrov,et al.  Circulating Endothelial Progenitor Cells and Coronary Collaterals in Patients with Non-ST Segment Elevation Myocardial Infarction , 2005, Journal of Vascular Research.

[81]  S. Fichtlscherer,et al.  Reduced Number of Circulating Endothelial Progenitor Cells Predicts Future Cardiovascular Events: Proof of Concept for the Clinical Importance of Endogenous Vascular Repair , 2005, Circulation.

[82]  A. Parenti,et al.  Morphological and phenotypical characterization of human endothelial progenitor cells in an early stage of differentiation , 2005, FEBS letters.

[83]  J. P. McCoy,et al.  Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry , 2005, Cytometry. Part B, Clinical cytometry.

[84]  A. Zeiher,et al.  Mobilizing endothelial progenitor cells. , 2005, Hypertension.

[85]  J. P. McCoy,et al.  Granulocyte Colony-Stimulating Factor Mobilizes Functional Endothelial Progenitor Cells in Patients With Coronary Artery Disease , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[86]  L. Tavazzi,et al.  Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. , 2005, Blood.

[87]  M. Pesce,et al.  SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. , 2004, Blood.

[88]  M. Tendera,et al.  Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ Stem Cells, and Mononuclear Cells Expressing Early Cardiac, Muscle, and Endothelial Markers Into Peripheral Blood in Patients With Acute Myocardial Infarction , 2004, Circulation.

[89]  K. Pollok,et al.  Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. , 2004, Blood.

[90]  M. Gnecchi,et al.  Cytokine-Induced Mobilization of Circulating Endothelial Progenitor Cells Enhances Repair of Injured Arteries , 2004, Circulation.

[91]  Geoffrey C Gurtner,et al.  Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 , 2004, Nature Medicine.

[92]  M. Matsuzaki,et al.  Low angiogenic potency induced by the implantation of ex vivo expanded CD117(+) stem cells. , 2004, American journal of physiology. Heart and circulatory physiology.

[93]  T. Chin,et al.  Rat cerebellar granule cells are protected from glutamate-induced excitotoxicity by S-nitrosoglutathione but not glutathione. , 2004, American journal of physiology. Cell physiology.

[94]  Hyun-Jae Kang,et al.  Characterization of Two Types of Endothelial Progenitor Cells and Their Different Contributions to Neovasculogenesis , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[95]  G. Schatteman,et al.  Hemangioblasts, angioblasts, and adult endothelial cell progenitors. , 2004, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.

[96]  M. Matsuzaki,et al.  CD117+ stem cells play a key role in therapeutic angiogenesis induced by bone marrow cell implantation. , 2003, American journal of physiology. Heart and circulatory physiology.

[97]  Shant Kumar,et al.  CD105 is important for angiogenesis: evidence and potential applications , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[98]  Arshed A. Quyyumi,et al.  Circulating Endothelial Progenitor Cells, Vascular Function, and Cardiovascular Risk , 2003 .

[99]  A. Rosenzweig.  Endothelial progenitor cells. , 2003, The New England journal of medicine.

[100]  I. Petit,et al.  Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. , 2002, Experimental hematology.

[101]  T. Asahara,et al.  Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo. , 2002, Experimental hematology.

[102]  S. Rafii,et al.  Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-Ligand , 2002, Cell.

[103]  J. Ornato,et al.  Acute coronary syndromes , 2002 .

[104]  T. Murohara,et al.  Mobilization of Endothelial Progenitor Cells in Patients With Acute Myocardial Infarction , 2001, Circulation.

[105]  S. Homma,et al.  Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function , 2001, Nature Medicine.

[106]  S. Rafii,et al.  Vascular Trauma Induces Rapid but Transient Mobilization of VEGFR2+AC133+ Endothelial Precursor Cells , 2001 .

[107]  S. Rafii,et al.  Vascular Trauma Induces Rapid but Transient Mobilization of VEGFR2+AC133+ Endothelial Precursor Cells , 2001, Circulation research.

[108]  D. Ribatti,et al.  Postnatal vasculogenesis , 2001, Mechanisms of Development.

[109]  S. Dirnhofer,et al.  Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells , 2000, The Lancet.

[110]  P. Carmeliet.  Mechanisms of angiogenesis and arteriogenesis , 2000, Nature Medicine.

[111]  S. Rafii,et al.  Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. , 2000, Blood.

[112]  I. Hampson,et al.  CD 105 antagonizes the inhibitory signaling of transforming growth factor b 1 on human vascular endothelial cells , 1999 .

[113]  J. Isner,et al.  Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. , 1999, Circulation research.

[114]  J. Isner,et al.  VEGF contributes to postnatal neovascularization by mobilizing bone marrow‐derived endothelial progenitor cells , 1999, The EMBO journal.

[115]  Haruchika Masuda,et al.  Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization , 1999, Nature Medicine.

[116]  M. Kennedy,et al.  A common precursor for hematopoietic and endothelial cells. , 1998, Development.

[117]  J. Kearney,et al.  AC133, a novel marker for human hematopoietic stem and progenitor cells. , 1997, Blood.

[118]  W. Risau,et al.  Mechanisms of angiogenesis , 1997, Nature.

[119]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[120]  M. Fackler,et al.  CD34: structure, biology, and clinical utility. , 1996, Blood.

[121]  J. Gutiérrez-Ramos,et al.  Expression of CD34 in endothelial cells, hematopoietic progenitors and nervous cells in fetal and adult mouse tissues , 1995, European journal of immunology.

[122]  M. Spanô,et al.  Flow cytometric analysis for reproductive biology , 1993, Biology of the cell.

[123]  B. G. Brown,et al.  Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators. , 1991, Circulation.

[124]  I. Bernstein,et al.  Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors , 1986 .

[125]  R. Andrews,et al.  Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. , 1986, Blood.